UBS Group’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

UBS Group’s Portfolio SMIH Stock Details SMIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-997	Closed	-$10K	–	11293
2022 Q4	$10K	Buy	997 +10	+1%	+$99	﹤0.01%	8586
2022 Q3	$10K	Hold	987	–	–	﹤0.01%	8526
2022 Q2	$10K	Buy	987 +5	+0.5%	+$49	﹤0.01%	8071
2022 Q1	$10K	Sell	982 -240	-20%	-$2.32K	﹤0.01%	8486
2021 Q4	$12K	Hold	1,222	–	–	﹤0.01%	8614
2021 Q3	$12K	Buy	+1,222	New	+$11.7K	﹤0.01%	7826

UBS Group's SMIH Position: Q1 2023 in Review

UBS Group sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q1 2023, closing a stake of 997 shares — an estimated $10K sold.

UBS Group first reported a position in SMIH in Q3 2021 and held it in 6 quarters. The position peaked at $12K in Q4 2021. 0 funds tracked by Wall St. Rank hold SMIH as of Q1 2023.

UBS Group reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
UBS Group sold 997 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $10K.
UBS Group first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
UBS Group's Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $12K in Q4 2021.
0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.